A Placebo- and Positive-Controlled Study of the Electrophysiological Effects of a Supratherapeutic Dose of LY2409021 in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 09 Mar 2012
At a glance
- Drugs Adomeglivant; Moxifloxacin
- Indications Hyperglycaemia
- Focus Pharmacodynamics
- 09 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 08 Nov 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.